IFITM3 and Alzheimer disease: In contrast, our study supports a beneficial role for IFITM3+ IRM in AD: PWK.APP/PS1 showed increased level of IRM compared to the other strains and are resilient to neurodegeneration at 8 months (Onos et al., 2019).